VARENICLINE TEVA 1 mg, film-coated tablet 56 tablets
Active ingredients: Varenicline citrate, Varenicline
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet56 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VARENICLINE TEVA 1 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC polyéthylène PVDC aluminium de 56 comprimé(s)
- Marketing authorisation holder
- TEVA (PAYS-BAS)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 10 Mar 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62500507CIP73029512CIP133400930295120Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| VARÉNICLINEcomprimé | 1 mg · un comprimé | FT |
| CITRATE DE VARÉNICLINEcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.